Effect of Nerve Stimulation on Sciatic Nerve Injury Pediatric Patients
Launched by AZEEM HOSPITAL, MULTAN · Jan 16, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called Faradic Nerve Stimulation (FNS) to see if it can help children recover from a condition called Post-Injection Sciatic Nerve Injury (PISNI). PISNI occurs when the sciatic nerve, which helps control leg muscles and feeling, gets hurt during an injection. This injury can cause leg pain, weakness, and trouble moving. The researchers want to find out if FNS can help children get better more quickly than just regular physiotherapy alone.
Children aged 3 to 19 who have been diagnosed with PISNI due to improper injections may be eligible to participate. If they join the study, they will be placed in one of two groups: one will receive FNS along with physiotherapy, while the other will get regular physiotherapy plus a similar treatment called TENS. All treatments will take place in a safe setting, and participants will attend sessions over a few months, with regular check-ins to monitor their progress. The goal is to find better ways to help children heal from nerve injuries, especially in areas where medical resources might be limited.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pediatric patients diagnosed with Post-Injection Sciatic Nerve Injury (PISNI) caused by improper intramuscular (IM) injections.
- • Children aged 3 to 19 years.
- • Parental consent for participation in the study.
- • Assent from the child (when applicable), depending on the age and understanding of the participant.
- Exclusion Criteria:
- • Children requiring surgical intervention for severe neurotmesis.
- • Patients with neurological or musculoskeletal conditions that may affect the outcomes (e.g., muscular dystrophy, multiple sclerosis).
- • Children who are unable to participate in physical therapy due to other medical conditions or severe limitations.
- • Children with severe systemic or other comorbid conditions that could interfere with study participation or outcome measures.
About Azeem Hospital, Multan
Azeem Hospital, located in Multan, is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through clinical trials. With a commitment to excellence in patient care and a robust infrastructure, Azeem Hospital seeks to contribute to the medical community by conducting innovative studies across various therapeutic areas. The hospital is staffed by a team of experienced clinicians and researchers who prioritize ethical standards and patient safety, ensuring that all clinical trials adhere to rigorous regulatory guidelines. By fostering collaboration between healthcare professionals and researchers, Azeem Hospital aims to bridge the gap between clinical practice and research, ultimately enhancing the quality of care provided to patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Multan, Punjab, Pakistan
Patients applied
Trial Officials
Prof Dr Muhammad Zia Ul Haq Professor-Supervisor, PhD
Study Director
Lincoln University College (LUC), Malaysia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported